Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 Role in Beta-cell Response to DPP-4 Inhibition
NCT02683187Phase 1Completed
- Start
- Mar 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Sitagliptin with Placebo (2 arms). Primary endpoint: Arginine-stimulated Insulin Secretion With and Without GLP-1 Blockade at 30 minutes. Started Mar 2017; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02683187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02683187.